Dr. Shih, Hsiu-Ming
Research Fellow
- 2789-9060 (Lab) (Room No: N605)
- 2652-3520 (Office)
- 2782-7654 (Fax)
-
Specialty:
- Protein-protein Interaction & Modification
- Cancer Cell Signaling
- Transcriptional Control
Education and Positions:
Ph.D. Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota
Highlight Detail
The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
Dr. Shih, Hsiu-Ming
Oncogene, Dec 03, 2012Acute promyelocytic leukemia (APL) is predominantly characterized by chromosomal translocations between the retinoic acid receptor, alpha (RARA) gene and the promyelocytic leukemia (PML) or promyelocytic leukemia zinc finger (PLZF) gene. In APL cells with PML/RARA fusions, arsenic trioxide and all-trans retinoic acid treatments specifically target the fusion protein for proteasome-dependent degradation